Literature DB >> 7262182

Antigen presentation and regulatory functions of human monocytes in the in vitro response of lymphocytes against purified protein derivative of tuberculin (PPD).

A J Treves, T Tal, V Barak, Z Fuks.   

Abstract

Monocyte functions in the primary and secondary proliferative responses of human lymphocytes against purified protein derivative of tuberculin (PPD) have been studied. By applying the antigens either directly to the responding cells or on antigen-treated autologous monocytes, it was possible to distinguish between two different monocyte functions: antigen presentation and regulation. Their helper function in lymphocyte proliferation was found in cell-free supernatants of autologous and allogeneic monocytes and was expressed better in the secondary rather than in the primary responses. The antigen-presenting function of monocytes, however, was found to be more substantial in the primary response of lymphocytes. These results suggest that macrophage dependency of certain immune functions should be considered in regard to the various functions of macrophages, since at least quantitative differences for each of the macrophage functions were found in the primary and secondary proliferative responses.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7262182     DOI: 10.1002/eji.1830110609

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Requirement of the T cell receptor for antigen presentation by T lymphocytes. Effect of envelope glycoproteins of HIV-1 on antigen presentation by T cells.

Authors:  N Chirmule; V S Kalyanaraman; H Slade; N Oyaizu; S Pahwa
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

Review 2.  Macrophage functions in antimicrobial defense.

Authors:  T Schaffner; H U Keller; M W Hess; H Cottier
Journal:  Klin Wochenschr       Date:  1982-07-15

3.  Characterization of cell mediated immune responses to the hepatitis B core protein in man.

Authors:  S P Sylvan; U B Hellström; B Flehmig
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.